India Grants a Compulsory Licence of Bayer's Patented Cancer Drug: The Issue of Local Working Requirement
European Journal of Risk Regulation, Vol. 2, pp. 247-250, 2012
4 Pages Posted: 1 Aug 2012
Date Written: May 1, 2012
The article analyses the first compulsory licence granted by the Indian government. The author argues that the decision adopted by India might be in violation of the non discrimination principle enshrined in Article 27(1) TRIPS Agreement.
Keywords: intellectual property, patents, pharmaceuticals, compulsory licences
Suggested Citation: Suggested Citation